All materials were obtained from commercial suppliers and used without further purification, unless otherwise noted. Starch-coated D-MNPs (50 mg/mL) were purchased from Chemicell GmbH (Berlin, Germany). β-glucosidase was sourced from Fisher Scientific (MP Biomedicals, Solon, OH, USA). Lacey carbon film-coated copper grids were obtained from Ted Pella (Redding, CA, USA). Iron standard (1,000 mg Fe/L) and yttrium internal standard (1,000 mg Fe/L) were purchased from GFS Chemicals (Powell, OH, USA). Methoxy PEG succinimidyl carboxymethyl ester (SC-NHS-PEG, 20 kDa) was obtained from Jenkem Technology (Beijing, People’s Republic of China). Glutaraldehyde solution (50%, w/v), 4-nitrophenyl β-D-glucopyranoside (GlcβNp), sodium phosphate (mono and dibasic), epichlorohydrin,
concentrated ammonium hydroxide (containing 30% ammonia), and
sodium hydroxide pellets were all obtained from Sigma-Aldrich (St Louis, MO, USA). All deionized water used in this study was produced using a
Milli-Q A10 Biocel water purification system (Millipore, Billerica, MA, USA).
Zhou J., Zhang J, & Gao W. (2014). Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, β-glucosidase-conjugated iron oxide nanoparticles. International Journal of Nanomedicine, 9, 2905-2917.